Skip to main content
A

AROA BIOSURGERY LIMITED — Investor Relations & Filings

Ticker · ARX ISIN · NZARXE0001S1 ASX Manufacturing
Filings indexed 329 across all filing types
Latest filing 2024-06-23 Regulatory Filings
Country AU Australia
Listing ASX ARX

About AROA BIOSURGERY LIMITED

https://aroa.com/

Aroa Biosurgery Limited specializes in the development and commercialization of regenerative medical devices for wound healing and soft tissue reconstruction. The company’s core technology is the AROA ECM platform, a proprietary extracellular matrix derived from ovine forestomach tissue. This scaffold-based technology is engineered to facilitate host cell infiltration and promote new blood vessel formation, supporting the body's natural healing process. The product portfolio includes Endoform for chronic and acute wound management, Myriad for complex surgical applications, and Symphony for skin substitute procedures. Additionally, the company manufactures the Ovitex and Ovitex PRS reinforced tissue matrices for hernia repair and breast reconstruction. These solutions target clinical needs in advanced wound care and surgical specialties by providing biological scaffolds that integrate into host tissue.

Recent filings

Filing Released Lang Actions
Annual Report to Shareholders 92 pages 8.6MB
Regulatory Filings
2024-06-23 English
Appendix 4G and Corporate Governance Statement 24 pages 603.9KB
Regulatory Filings
2024-06-23 English
Notice of AGM Date and Director Nomination Closing Date 1
Regulatory Filings
2024-05-23 English
FY24 Appendix 4E and Full Year Results 47 pages 3.1MB
Regulatory Filings
2024-05-20 English
FY24 Full Year Results Presentation 27 pages 1.5MB
Regulatory Filings
2024-05-20 English
Notification of Full Year Results Webinar 1 page 12
Regulatory Filings
2024-05-13 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.